Perplexity is finalizing a new funding round that would value it at $9 billion—triple its valuation from just a few months ago—the latest sign of continued investor excitement for artificial ...

Abstract and Introduction Rationale for i.v. Antihypertensive Selection Clinical Pharmacology of i.v. Antihypertensives References There are potential concerns with the use of sodium nitroprusside ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Bonus Nov 10, 1996 Dec 10, 1996 Oct 31, 1996 Bonus Ratio: 1 share(s) for every 2 shares held Bonus Nov 29, 1991 Dec 30, 1991 Sep 30, 1991 Bonus Ratio: 1 share(s) for every 2 shares held Bonus-Apr 29, ...